CYT997
- Generic Name
- CYT997
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 2GTU230HA1
- Background
CYT997 is an orally available vascular argeting and cytotoxic agent that has proven effective in animal models of a wide range of tumour types including breast, prostate and colon, as well as some leukemias.
- Indication
Investigated for use/treatment in solid tumors.
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy Study of CYT997 in Multiple Myeloma
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 5
- Registration Number
- NCT00664378
- Locations
- 🇦🇺
The Alfred Hospital, Melbourne, Victoria, Australia
Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
- First Posted Date
- 2008-04-02
- Last Posted Date
- 2013-05-03
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT00650949
- Locations
- 🇦🇺
Royal North Shore Hospital, St-Leonards, New South Wales, Australia
🇦🇺Flinders Medical Centre, Bedford Park, South Australia, Australia
🇦🇺Gold Coast Hospital, Southport, Queensland, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath